Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 338
Articles

Top Line Results from the Phase 3 Lp(a)HORIZON Trial

On September 4, 2026, Novartis announced the topline results of its phase 3 Lp(a)HORIZON trial. Novartis shared that while pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the trial failed to reduce the risk of major adverse cardiovascular…

Read More |
Podcasts

S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results

Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science…

Listen Now | 15:39 |
Podcasts

Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That’s Changing Everything

Familial chylomicronemia syndrome (FCS) is one of the rarest and most challenging lipid disorders to manage, but the landscape is changing rapidly. In this Industry…

Listen Now | 23:49 |
Articles

Make Your Voice Heard: Support LDL-C Quality Measurement in the CMS CY 2027 Physician Fee Schedule

The Centers for Medicare & Medicaid Services (CMS) is accepting public comments on the Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule, and…

Read More |
Podcasts

S7E9: HDL Under the Microscope: Setting the Record Straight with Dr. Lipid

In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as “Dr. Lipid”…

Listen Now | 28:30 |
Infographics

ICD-10 Codes

ICD-10

Read More |
Podcasts

Industry Innovations | Episode 6: Guidelines in Action

The guidelines exist. The evidence is clear. So why does the gap between what we know and what we do in practice persist? In this…

Listen Now | 38:20 |
Podcasts

Industry Innovations | Episode 5: Statin Intolerance in Focus: Navigating Side Effects, Patient Concerns, and the Path to Optimal LDL Lowering

When two past NLA Presidents and seasoned podcast hosts sit down together, the conversation is bound to be something special. In this Industry Innovations episode,…

Listen Now | 26:35 |